Treatment of Somatization Disorder with Nefazodone: A Prospective, Open-Label Study

By Menza M.  

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 13, Iss. 3, 2001-09 ,pp. : 153-158

Springer Publishing Company

Access to resources Recommend Favorite

Olanzapine in the treatment of depression with psychotic features: A prospective open-label study

By Adli Mazda   Wiethoff Katja   Baethge Christopher   Pfennig Andrea   Stamm Thomas   Bauer Michael  

International Journal of Psychiatry in Clinical Practice, Vol. 12, Iss. 3, 2008-01 ,pp. : 202-209

Ashgate Publishing Ltd

Access to resources Recommend Favorite

STX209 (Arbaclofen) for Autism Spectrum Disorders: An 8-Week Open-Label Study

By Erickson Craig   Veenstra-Vanderweele Jeremy   Melmed Raun   McCracken James   Ginsberg Lawrence   Sikich Linmarie   Scahill Lawrence   Cherubini Maryann   Zarevics Peter   Walton-Bowen Karen   Carpenter Randall   Bear Mark   Wang Paul   King Bryan  

Journal of Autism and Developmental Disorders, Vol. 44, Iss. 4, 2014-04 ,pp. : 958-964

Springer Publishing Company

Access to resources Recommend Favorite

A prospective, open-label study of milnacipran in the prevention of headache in patients with episodic or chronic migraine

By Engel Emily   Kudrow David   Rapoport Alan  

Neurological Sciences, Vol. 35, Iss. 3, 2014-03 ,pp. : 429-435

Springer Publishing Company

Access to resources Recommend Favorite

An Open-label Study of Tiagabine as Augmentation Therapy for Anxiety

By Schwartz Thomas   Azhar Nouman   Husain Juhi   Nihalani Nikhil   Simionescu Mihai   Coovert Douglas   Jindal Shefali   Tirmazi Syed  

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 17, Iss. 3, 2005-07 ,pp. : 167-172

Informa Healthcare

Access to resources Recommend Favorite